The Best Pharmacies, New Pharmacy Degrees, and More News
Small Doses is back, bringing pharmacists the latest clinical and professional news you missed this month.
Why I Still Recommend the Pharmacist Profession
Pharmacy has changed a lot in the last 50 years-but a lot of that has been for the good of the profession and the public.
FDA, Chains Fight for Flu Vaccines
After a bad 2017 season, pharmacies and the FDA are pushing the public to still get flu vaccines.
Advances in Hepatitis C Treatment
This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.
What Pharmacists Need to Know About Lofexidine
FDA approves lofexidine for opioid withdrawal symptoms.
What the FDA Needs to Do
There are a lot of factors that go into medication errors-pharmacists are stepping up, but the FDA must also act.
FDA Offers Pharmacists Opioid Training
A new FDA plan will offer new education opportunities for a variety of healthcare workers.
Pharmacists Help Meet Value-Based Targets
Pharmacists add value, but you need to show that to health-system executives.
The 3 Things I Wish I’d Known in Pharmacy School
What one pharmacist says he wishes he’d prioritized sooner.
Why Pharmacists Need to Change Their Attitude
The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.
Understaffing: The cancer on our profession
Why one pharmacist thinks pharmacy education is being wasted.
How to Prevent the Top 4 Medication Errors
Drug errors generally fall into one of four categories-here's how the experts say those errors can be eliminated.
Apixaban Is Only NOAC with Lower Stroke Rate for Both Doses Compared to Warfarin in Large Study
A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.
Why Drug Labels Are Set Up for Failure
Tall man lettering is supposed to help reduce medication errors-but some say it doesn’t go far enough.
Online Pharmacies, Formulary Exclusions, and More News
The September Small Doses brings you the latest news that affects pharmacists.
How to Protect Yourself from Red Flags
Why pharmacists need to be paying attention to the Trinity II case and its consequences.
What Pharmacists Need to Know About Epidiolex
The FDA recently approved cannabidiol oral solution to treat seizures.
The Push Is on for Generics and Biosimilars
Stalled competition hurts consumers and may keep prices higher.
What Pharmacists Need to Know About HIV Treatment and Prevention
1.1 million Americans live with HIV-here’s how you can help.
What You Need to Know About ADHD Medications
How pharmacists can help students get the treatments they need.
What the FDA Wants Pharmacists to Know About Generic Drugs
Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.
The Tools That Help Stabilize EpiPen Shortage
The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.
A Look at the Year in Generics
The annual report on generic access and savings shows some impressive numbers for 2017.
What Pharmacists Need to Know About Erenumab-aooe
The latest New Drug Review covers Amgen’s migraine medication.
The 4 Policy Changes Hitting Pharmacies
What the experts have to say about recent shifts in pharmacy law and practice.
NSAIDs with Anticoagulants Are “Double Trouble” for AF Patients
FDA-Mandated Biosimilar Names Are Confusing
An unclear naming system for biosimilars could affect patient safety.
Thoughts on Maximillian Kolbe and the Opioid Crisis
Opioid Limits, CVS Tackles Drug Prices, and More Pharmacy News
Small Doses is back, bringing you the pharmacy news you need in a way that works for you.
What Bartenders and Pharmacists Have in Common
Turns out running a bar shares many similarities with running a pharmacy-but the mistakes cost a lot more.
